Unilens Corp. USA, a prominent player in the optical industry, is headquartered in the United States and operates extensively across North America. Founded in 1988, the company has established itself as a leader in the development and manufacturing of innovative contact lenses and related products. Unilens is renowned for its unique offerings, including specialty contact lenses designed for specific vision needs, which set it apart in a competitive market. The company has achieved significant milestones, including advancements in lens technology that enhance comfort and visual clarity. With a strong market position, Unilens Corp. USA continues to be recognised for its commitment to quality and innovation, making it a trusted choice for eye care professionals and consumers alike.
How does Unilens Corp. USA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Unilens Corp. USA's score of 40 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Unilens Corp. USA, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Bausch Health Companies Inc., which influences its climate commitments and reporting practices. While Unilens Corp. USA does not have its own documented reduction targets, it inherits sustainability initiatives and targets from its parent company, Bausch Health Companies Inc. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are cascaded down to Unilens at a level 2 relationship. As part of its corporate family, Unilens is aligned with Bausch Health's broader climate strategies, although specific reduction targets or achievements for Unilens itself are not detailed. The company is expected to adhere to the sustainability goals set by its parent organisation, reflecting a commitment to reducing carbon emissions and enhancing environmental responsibility within the industry context.
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2018 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | - | - | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 00,000,000 | 00,000,000 |
Unilens Corp. USA's Scope 3 emissions, which increased by 41% last year and increased by approximately 41% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 21% of total emissions under the GHG Protocol, with "Waste Generated in Operations" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Unilens Corp. USA has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.